Selected research
Market Structure
Global Propofol Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Propofol Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Propofol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Propofol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Propofol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Propofol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Propofol Injection include Pfizer, B. Braun Medical, AstraZeneca, Wellona Pharma, Rusoma Laboratories, Neon Laboratories Limited, Fresenius Kabi and Centurion Healthcare Private Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Propofol Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Propofol Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Propofol Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Propofol Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Propofol Injection Segment by Company
Pfizer
B. Braun Medical
AstraZeneca
Wellona Pharma
Rusoma Laboratories
Neon Laboratories Limited
Fresenius Kabi
Centurion Healthcare Private Limited
Propofol Injection Segment by Type
Propofol Medium/Long Chain Fat Emulsion Injection
Propofol Emulsion Injection
Propofol Injection Segment by Application
Hospital
Clinic
Other
Propofol Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Propofol Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Propofol Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Propofol Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Propofol Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Propofol Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Propofol Medium/Long Chain Fat Emulsion Injection
- Propofol Emulsion Injection
Applications
- Hospital
- Clinic
- Other
Companies covered
- Pfizer
- B. Braun Medical
- AstraZeneca
- Wellona Pharma
- Rusoma Laboratories
- Neon Laboratories Limited
- Fresenius Kabi
- Centurion Healthcare Private Limited
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Propofol Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Propofol Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Propofol Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Propofol Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Propofol Injection Market Dynamics
- 2.1 Propofol Injection Industry Trends
- 2.2 Propofol Injection Industry Drivers
- 2.3 Propofol Injection Industry Opportunities and Challenges
- 2.4 Propofol Injection Industry Restraints
3 Propofol Injection Market by Manufacturers
- 3.1 Global Propofol Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Propofol Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Propofol Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Propofol Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Propofol Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Propofol Injection Manufacturers, Product Type & Application
- 3.7 Global Propofol Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Propofol Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Propofol Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Propofol Injection Tier 1, Tier 2, and Tier 3
4 Propofol Injection Market by Type
- 4.1 Propofol Injection Type Introduction
- 4.1.1 Propofol Medium/Long Chain Fat Emulsion Injection
- 4.1.2 Propofol Emulsion Injection
- 4.2 Global Propofol Injection Sales by Type
- 4.2.1 Global Propofol Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Propofol Injection Sales by Type (2021-2032)
- 4.2.3 Global Propofol Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Propofol Injection Revenue by Type
- 4.3.1 Global Propofol Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Propofol Injection Revenue by Type (2021-2032)
- 4.3.3 Global Propofol Injection Revenue Market Share by Type (2021-2032)
5 Propofol Injection Market by Application
- 5.1 Propofol Injection Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Propofol Injection Sales by Application
- 5.2.1 Global Propofol Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Propofol Injection Sales by Application (2021-2032)
- 5.2.3 Global Propofol Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Propofol Injection Revenue by Application
- 5.3.1 Global Propofol Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Propofol Injection Revenue by Application (2021-2032)
- 5.3.3 Global Propofol Injection Revenue Market Share by Application (2021-2032)
6 Global Propofol Injection Sales by Region
- 6.1 Global Propofol Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Propofol Injection Sales by Region (2021-2032)
- 6.2.1 Global Propofol Injection Sales by Region (2021-2026)
- 6.2.2 Global Propofol Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Propofol Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Propofol Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Propofol Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Propofol Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Propofol Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Propofol Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Propofol Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Propofol Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Propofol Injection Revenue by Region
- 7.1 Global Propofol Injection Revenue by Region
- 7.1.1 Global Propofol Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Propofol Injection Revenue by Region (2021-2026)
- 7.1.3 Global Propofol Injection Revenue by Region (2027-2032)
- 7.1.4 Global Propofol Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Propofol Injection Revenue (2021-2032)
- 7.2.2 North America Propofol Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Propofol Injection Revenue (2021-2032)
- 7.3.2 Europe Propofol Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Propofol Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Propofol Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Propofol Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Propofol Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Pfizer
- 8.1.1 Pfizer Company Information
- 8.1.2 Pfizer Business Overview
- 8.1.3 Pfizer Propofol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Pfizer Propofol Injection Product Portfolio
- 8.1.5 Pfizer Recent Developments
- 8.2 B. Braun Medical
- 8.2.1 B. Braun Medical Company Information
- 8.2.2 B. Braun Medical Business Overview
- 8.2.3 B. Braun Medical Propofol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 B. Braun Medical Propofol Injection Product Portfolio
- 8.2.5 B. Braun Medical Recent Developments
- 8.3 AstraZeneca
- 8.3.1 AstraZeneca Company Information
- 8.3.2 AstraZeneca Business Overview
- 8.3.3 AstraZeneca Propofol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 AstraZeneca Propofol Injection Product Portfolio
- 8.3.5 AstraZeneca Recent Developments
- 8.4 Wellona Pharma
- 8.4.1 Wellona Pharma Company Information
- 8.4.2 Wellona Pharma Business Overview
- 8.4.3 Wellona Pharma Propofol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Wellona Pharma Propofol Injection Product Portfolio
- 8.4.5 Wellona Pharma Recent Developments
- 8.5 Rusoma Laboratories
- 8.5.1 Rusoma Laboratories Company Information
- 8.5.2 Rusoma Laboratories Business Overview
- 8.5.3 Rusoma Laboratories Propofol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Rusoma Laboratories Propofol Injection Product Portfolio
- 8.5.5 Rusoma Laboratories Recent Developments
- 8.6 Neon Laboratories Limited
- 8.6.1 Neon Laboratories Limited Company Information
- 8.6.2 Neon Laboratories Limited Business Overview
- 8.6.3 Neon Laboratories Limited Propofol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Neon Laboratories Limited Propofol Injection Product Portfolio
- 8.6.5 Neon Laboratories Limited Recent Developments
- 8.7 Fresenius Kabi
- 8.7.1 Fresenius Kabi Company Information
- 8.7.2 Fresenius Kabi Business Overview
- 8.7.3 Fresenius Kabi Propofol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Fresenius Kabi Propofol Injection Product Portfolio
- 8.7.5 Fresenius Kabi Recent Developments
- 8.8 Centurion Healthcare Private Limited
- 8.8.1 Centurion Healthcare Private Limited Company Information
- 8.8.2 Centurion Healthcare Private Limited Business Overview
- 8.8.3 Centurion Healthcare Private Limited Propofol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Centurion Healthcare Private Limited Propofol Injection Product Portfolio
- 8.8.5 Centurion Healthcare Private Limited Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Propofol Injection Value Chain Analysis
- 9.1.1 Propofol Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Propofol Injection Production Mode & Process
- 9.2 Propofol Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Propofol Injection Distributors
- 9.2.3 Propofol Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst